Information sheet for parents after a child's first simple febrile seizure
Official title: Impact d'Une Fiche Explicative donnée Aux Parents après Une première Consultation Pour Crise fébrile Simple au Service d'Accueil Des Urgences pédiatriques du CHU de Strasbourg
Run by University Hospital, Strasbourg, France · NCT07335640 · Data updated 2026-11-12
This tries giving parents a clear information sheet after their child's first simple febrile seizure to see if it lowers parental anxiety and reduces extra emergency visits.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 9 Months to 5 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | June 11, 2025 |
| Main results expected | June 2026 |
| Study ends | June 11, 2026 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT07335640 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 9 months to 5 years presenting to the CHU de Strasbourg pediatric emergency unit with a first or second simple febrile seizure and with at least one parent present are ideal candidates.
✕Probably not a fit
Children with focal or prolonged seizures, non-febrile seizures, prior neurological disorders, age outside 9 months–5 years, or more than two prior simple febrile seizures are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
At Strasbourg University Hospital's pediatric emergency unit, researchers are observing children aged 9 months to 5 years who present with a first or second simple febrile seizure between January 1, 2022 and May 1, 2025. An explanatory information sheet was implemented at the SAUP in July 2023, and the study compares rates of return visits for recurrent simple febrile seizures and early consultations for isolated fever before and after that implementation. Eligible patients must meet clinical criteria for simple febrile seizure (generalized seizure <15 minutes, no postictal deficit, no recurrence within 24 hours) and have a parent present at the consultation. Outcomes focus on emergency return visit rates and indicators of parental anxiety reflected by early fever presentations.
Why it matters
Potential benefit: If successful, this could reduce unnecessary emergency visits and lower parental anxiety about fevers and seizures.
How similar studies have gone: Previous parent-education programs about fever and febrile seizures have generally reduced anxiety and unnecessary care, though effects vary by format and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit) * First visit to the SAUP for a simple febrile seizure * Meeting the clinical criteria for FCS: * Generalized seizure lasting less than 15 minutes * No post-critical deficit * No recurrence of seizures within 24 hours * No personal history of neurological disorders * Occurrence between January 1, 2022, and May 1, 2025 * First or second episode of FSFS at the time of consultation * Presence of one of the two parents during the consultation at the SAUP Exclusion Criteria: * Patient already seen at the SAUP for FCS * Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department. * Child who does not meet the criteria for simple febrile seizures: * aged less than 9 months or more than 5 years at the time of diagnosis. * Non-febrile seizure * Focal seizure * Seizure duration \>15 min * Presence of post-critical deficit * Multiple seizures within 24 hours * Personal neurological history. * Seizure occurring outside the period of interest (January 1, 2022 to May 1, 2025) * Absence of parents during the SAUP consultation
Where it's running
-
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Sarah Baer, MD
- Email: sarah.baer@chru-strasbourg.fr
- Phone: 33 3 88 12 63 98
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.